Chemoinformaics analysis of 2-Epi-Jatrogrossidione
| Molecular Weight | 312.409 | nRot | 1 |
| Heavy Atom Molecular Weight | 288.217 | nRig | 19 |
| Exact Molecular Weight | 312.173 | nRing | 3 |
| Solubility: LogS | -3.966 | nHRing | 0 |
| Solubility: LogP | 3.152 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 47 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 51.809 |
| nHD | 1 | BPOL | 25.813 |
| QED | 0.803 |
| Synth | 4.492 |
| Natural Product Likeliness | 1.63 |
| NR-PPAR-gamma | 0.476 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.638 |
| Pgp-sub | 0.042 |
| HIA | 0.005 |
| CACO-2 | -4.648 |
| MDCK | 0.0000142 |
| BBB | 0.91 |
| PPB | 0.930488 |
| VDSS | 1.417 |
| FU | 0.0297174 |
| CYP1A2-inh | 0.11 |
| CYP1A2-sub | 0.944 |
| CYP2c19-inh | 0.15 |
| CYP2c19-sub | 0.926 |
| CYP2c9-inh | 0.32 |
| CYP2c9-sub | 0.876 |
| CYP2d6-inh | 0.031 |
| CYP2d6-sub | 0.311 |
| CYP3a4-inh | 0.651 |
| CYP3a4-sub | 0.709 |
| CL | 1.817 |
| T12 | 0.033 |
| hERG | 0.046 |
| Ames | 0.236 |
| ROA | 0.501 |
| SkinSen | 0.043 |
| Carcinogencity | 0.048 |
| EI | 0.016 |
| Respiratory | 0.879 |
| NR-Aromatase | 0.683 |
| Antiviral | No |
| Prediction | 0.751958 |